GlassScriptPhysician profile
Chris R Longbella
NPI 1992804413
$1,732.69
in general payments reported to CMS, 2019-2025
23 companies · $357 in 2025
The $357 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $177 · 2021: $209 · 2022: $328 · 2023: $218 · 2024: $146 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $835.27 | 2019-2025 | |
| Astellas Pharma US INC | $142.14 | 2019-2025 | Veozah |
| Pfizer INC. | $89.12 | 2022-2025 | |
| Coopersurgical, INC. | $74.20 | 2021-2023 | Mara Console |
| Sage Therapeutics, LLC | $64.69 | 2024-2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $53.23 | 2019-2023 | Gardasil 9 |
| Organon LLC | $47.18 | 2022-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $45.11 | 2025 | Myfembree |
| Amag Pharmaceuticals, INC. | $39.52 | 2019 | |
| Hologic Sales and Service, LLC | $39.08 | 2021-2022 | |
| Roche Diagnostics Corporation | $37.78 | 2019 | |
| Novo Nordisk INC | $37.43 | 2025 | Wegovy |
| Covidien LP | $33.17 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.97 | 2019-2024 | |
| Therapeuticsmd, INC. | $24.69 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $21.11 | 2023 | Endo Stitch |
| Takeda Pharmaceuticals U.S.A., INC. | $20.26 | 2019 | |
| Corium, LLC | $19.87 | 2022 | |
| Boston Scientific Corporation | $18.01 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.18 | 2025 | Xifaxan |
| Sobi, INC | $16.01 | 2020 | |
| Channel Medsystems, INC. | $15.37 | 2023 | |
| Allergan, INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Longbella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.